Regulators Stand Up for Biosimilars
Development of biosimilars has expanded patients’ treatment options by offering innovative medicine at lower costs than traditional biologics. So why are some nations slow to adopt biosimilars?
Biosimilar Briefings Review Nature and Impact of Biosimilars on Access
Physicians across Latin America are coming together to discuss a timely topic: what access to biosimilars means to their patients.
Portugal Confirms Patient Role in Treatment Decisions
Do patients have a say in what drug they’re given at hospital? In Portugal, the National Commission for Pharmacy and Therapeutics gave a resounding “yes” this month with a newly released clarification document. The document addresses the use of biosimilars and any switching from a reference product to a biosimilar. The issue was the subject […]
In Europe, Advocates Emphasize Role of Patient Voice
Patient advocacy organisations know the power of the patient voice when it comes to accessing medicine. Just consider Arthritis Ireland. As highlighted during a recent Global Alliance for Patient Access webinar, the group saw patient input make a difference during the country’s experience with access to lidocaine patches. The medication numbs the skin to help […]
